142 related articles for article (PubMed ID: 33662543)
1. Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study.
Danion F; Duval C; Séverac F; Bachellier P; Candolfi E; Castelain V; Clere-Jehl R; Denis J; Dillenseger L; Epailly E; Gantzer J; Guffroy B; Hansmann Y; Herbrecht JE; Letscher-Bru V; Leyendecker P; Le Van Quyen P; Ludes PO; Morel G; Moulin B; Paillard C; Renaud-Picard B; Roche AC; Sabou M; Schneider F; Solis M; Talagrand-Reboul E; Veillon F; Ledoux MP; Simand C; Herbrecht R;
Clin Microbiol Infect; 2021 Nov; 27(11):1644-1651. PubMed ID: 33662543
[TBL] [Abstract][Full Text] [Related]
2. Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography.
Akahoshi Y; Kimura SI; Gomyo A; Hayakawa J; Tamaki M; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Nakasone H; Kako S; Kanda Y
Infect Dis (Lond); 2018 Apr; 50(4):280-288. PubMed ID: 29087731
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
4. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
Upton A; Kirby KA; Carpenter P; Boeckh M; Marr KA
Clin Infect Dis; 2007 Feb; 44(4):531-40. PubMed ID: 17243056
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
Resendiz-Sharpe A; Mercier T; Lestrade PPA; van der Beek MT; von dem Borne PA; Cornelissen JJ; De Kort E; Rijnders BJA; Schauwvlieghe AFAD; Verweij PE; Maertens J; Lagrou K
J Antimicrob Chemother; 2019 Sep; 74(9):2759-2766. PubMed ID: 31236587
[TBL] [Abstract][Full Text] [Related]
6. Higher mortality of severe influenza patients with probable aspergillosis than those with and without other coinfections.
Ku YH; Chan KS; Yang CC; Tan CK; Chuang YC; Yu WL
J Formos Med Assoc; 2017 Sep; 116(9):660-670. PubMed ID: 28647219
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study.
Rubio PM; Sevilla J; González-Vicent M; Lassaletta A; Cuenca-Estrella M; Díaz MA; Riesco S; Madero L
J Pediatr Hematol Oncol; 2009 Sep; 31(9):642-6. PubMed ID: 19684521
[TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
Marr KA; Carter RA; Boeckh M; Martin P; Corey L
Blood; 2002 Dec; 100(13):4358-66. PubMed ID: 12393425
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, utilisation of healthcare resources and outcome of invasive fungal diseases following paediatric allogeneic haematopoietic stem cell transplantation.
Linke C; Ehlert K; Ahlmann M; Fröhlich B; Mohring D; Burkhardt B; Rössig C; Groll AH
Mycoses; 2020 Feb; 63(2):172-180. PubMed ID: 31661569
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of invasive aspergillosis in France: a six-year multicentric survey in the Greater Paris area.
Cornet M; Fleury L; Maslo C; Bernard JF; Brücker G;
J Hosp Infect; 2002 Aug; 51(4):288-96. PubMed ID: 12183144
[TBL] [Abstract][Full Text] [Related]
12. Airborne fungal spores and invasive aspergillosis in hematologic units in a tertiary hospital during construction: a prospective cohort study.
Park JH; Ryu SH; Lee JY; Kim HJ; Kwak SH; Jung J; Lee J; Sung H; Kim SH
Antimicrob Resist Infect Control; 2019; 8():88. PubMed ID: 31161035
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients.
Mikulska M; Raiola AM; Bruno B; Furfaro E; Van Lint MT; Bregante S; Ibatici A; Del Bono V; Bacigalupo A; Viscoli C
Bone Marrow Transplant; 2009 Sep; 44(6):361-70. PubMed ID: 19308042
[TBL] [Abstract][Full Text] [Related]
14. Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?
Georgiadou SP; Kontoyiannis DP
J Infect; 2012 Sep; 65(3):262-8. PubMed ID: 22580034
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.
Reinwald M; Konietzka CA; Kolve H; Uhlenbrock S; Ahlke E; Hummel M; Spiess B; Hofmann WK; Buchheidt D; Groll AH
Mycoses; 2014 Sep; 57(9):537-43. PubMed ID: 24655146
[TBL] [Abstract][Full Text] [Related]
16. Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Jin J; Wu D; Liu Y; Pan S; Yan JL; Aram JA; Lou YJ; Meng H; Chen X; Zhang X; Schwartz IS; Patterson TF
BMC Infect Dis; 2019 May; 19(1):471. PubMed ID: 31138134
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of the association of the expression and single nucleotide polymorphisms (SNPs) of the TLR4, PTX3 and Dectin-1 (CLEC/A) genes with development of invasive aspergillosis among haematopoietic stem cell transplant recipients with oncohaematological disorders.
Kalkanci A; Tug E; Fidan I; Guzel Tunccan O; Ozkurt ZN; Yegin ZA; Sahin EA; Kuralay Z
Mycoses; 2020 Aug; 63(8):832-839. PubMed ID: 32291814
[TBL] [Abstract][Full Text] [Related]
18. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
[TBL] [Abstract][Full Text] [Related]
19. Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
Satyanarayana G; Enriquez KT; Sun T; Klein EJ; Abidi M; Advani SM; Awosika J; Bakouny Z; Bashir B; Berg S; Bernardes M; Egan PC; Elkrief A; Feldman LE; Friese CR; Goel S; Gomez CG; Grant KL; Griffiths EA; Gulati S; Gupta S; Hwang C; Jain J; Jani C; Kaltsas A; Kasi A; Khan H; Knox N; Koshkin VS; Kwon DH; Labaki C; Lyman GH; McKay RR; McNair C; Nagaraj G; Nakasone ES; Nguyen R; Nonato TK; Olszewski AJ; Panagiotou OA; Puc M; Razavi P; Robilotti EV; Santos-Dutra M; Schmidt AL; Shah DP; Shah SA; Vieira K; Weissmann LB; Wise-Draper TM; Wu U; Wu JT; Choueiri TK; Mishra S; Warner JL; French B; Farmakiotis D
Open Forum Infect Dis; 2022 Mar; 9(3):ofac037. PubMed ID: 35198648
[TBL] [Abstract][Full Text] [Related]
20. Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.
El-Cheikh J; Castagna L; Wang L; Esterni B; Faucher C; Fürst S; Pierre B; Mohty M; Blaise D
Leuk Lymphoma; 2010 Sep; 51(9):1705-10. PubMed ID: 20629522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
